Leprosy Mailing List – August 16, 2020
Ref.: (LML) a change in our thinking about the disease leprosy and its epidemiology
From: Laila de Laquiche, Parana, Brazil
Dear colleagues,
The comments of Prof. Naafs in the LML of the 10th of August made me think of the story of Mary Mallon: healthy carrier of Typhoid Fever.
What will be the turning point between the healthy carrier and the subclinical patient in Leprosy? What's the definition of disease? Much to learn in Leprology; I have this doubt that haunts me.
Would advances in diagnostic tests be enlightening or a confusing factor in clinical reasoning?
Prof. Naafs thanks for instigating and always making us think about the pathophysiology of the disease!
Best regards!
Os comentários na LML do dia 10 de Agosto fez-me pensar na história de Mary Mallon: portadora saudável de Febre Tifóide...
Qual será o "divisor de águas" entre o portador saudável e o doente subclínico na Lepra?
Eu que tenho ainda muito a aprender em Leprologia, tenho esta dúvida que me persegue. Os avanços dos exames diagnósticos seriam esclarecedores ou um fator de confusão do raciocínio clínico?
Obrigada por instigar e fazer-nos pensar sempre na fisiopatologia da doença.
Cordialmente,
Enclosed annual report 2019 of the Alliance Against Leprosy
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/9879a87e-d324-4a7e-a403-4f40403b2c0co%40googlegroups.com.
No comments:
Post a Comment